control debat
devic perform in-lin modestli lag
healthcar market react concern
note impact favor supplier bd baxter
us-centr small-cap axon implant
organ devic growth weak dynam
devic trade in-lin amidst challeng month februari worst
month sinc decemb end worst week sinc
financi crisi medic devic perform line vs
februari amidst broader equiti sell-off driven concern
rel healthcar devic under-perform pt lift
broader sector driven select stock like gilead given vaccin
deriv provid despit volatil day-to-day perform elect
news nevada caucu result drive mco hsd day close
month slightli ahead pharma devic tool although growth
outperform valu month perform converg last
week growth valu news report manag team
style sever devic compani quantifi impact see thought
alcon suggest greatest impact china sale like
lost februari march medtech rel valuat premium compress
month large-cap coverag trade premium
 vs enter year averag premium
impact med-tech sub-sector origin wrote see
potenti impact algorithm could consumer-fac
discretionari procedur impact envista alcon implant
compani less discretionari natur includ cardio orthoped
supplier insul compani less procedur focus
could potenti see isol flu deriv benefit bd baxter
implant compani gener fare wors zimmer
biomet boston worst perform past
week baxter bd modestli outperform sinc
opposit expect true howev discretionari name
alcon envista outperform med-tech past week though alcon
also influenc earn strength envista earli
underperform broad concern aros small-cap primarili us-
orient busi axon also outperform net hard
discern definit diverg categori given idiosyncrat dynam
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
within past week small cap supplier may continu rel
safe-haven sell-off continu
devic momentum broke trend devic growth
impli bp momentum deceler vast major coverag
report earn snap notabl trend devic
shown level momentum acceler everi past
year averag bp minimum bp although idiosyncrat dynam
bd contribut bp result even ex-bd/mdt
momentum across coverag deceler bp could view
rel stabil vs materi deceler result still bp
histor averag would impact result
difficult attribut momentum deceler specif caus
see time holiday strong potenti factor select
manag team note time christma new year day-
mid-week- may result fewer rel sell day given person
time-off devic momentum acceler bp admittedli
basi momentum still acceler bp even light weaker
model impli organ growth bp momentum
deceler see china key variabl result
analyz outperform month februari axon share
climb higher follow januari pre-announc us
revenu vs mse medtron commentari
snm sale flat y/i send approv may may
earli spring remain confid axon share gain market growth
follow januari ceo lunch see avano recov
low result reflect first quarter
organ growth year compani new cfo place
manag provid updat indic erp implement suppli
chain challeng resolv visibl on-q stabil margin progress
remain challeng see deliv street
ep expect global patient expect
see growth see conserv maintain model
see alcon surgic busi show upsid mse
street driven panoptix vision momentum-st adjust
japan impact importantli guidanc solid see
manag confid deliv top-line ep target even
signific china impact derisk event
underperform larg idiosyncrat driver
focu downgrad stock rel underweight given continu
volum pressur sinc novemb impli structur slowdown
busi especi follow publish better-match jama studi
like dampen impella referr channel prospect
under-perform follow earn manag referenc puls
commerci revenu recognit like delay month
see ii convert bond price although near-term
dilut minim offer like accret ep see
envista share trade sinc earn compani
miss two consecut quarter post-separ investor concern
arisen regard compani potenti china impact result ceo
amir aghdaei disclos februari procedur delay ceo
call seri see share move lower follow
alari ship hold announc coupl larg uncertain resolut
timelin lesser extent lower guidanc acceler china
tender pressur impact note fundament rest
busi remain sound swift pump resolut could drive relief
rel valuat premium slightli recent histori large-
cap coverag end januari turn reflect
premium premium fallen point
high mid-to-l remain mid high-teen last
month discuss devic out-performance recent year
tale improv fundament name acceler organ growth margin
expans rel insul broader price regulatori risk versu
sub-sector healthcar continu hold view sustain
out-performance depend acceler least
maintain organ growth valuat premium remain meaning
medic devic track exactli in-lin ytd
devic outperform broader healthcar nearli pt trend
revers given biotech elect dynam best perform
ytd devic outperform pt outperform
healthcar sector pt
partial recoveri follow first quarter organ growth year
profit guidanc view conserv
surgic strength guidanc solid despit china greater transpar
continu volum pressur impli structrual slowdown ms d/g underweight
alari hold announc larg uncertain resolut timelin
valuat med-tech coverag univers end februari pt
january-end includ johnson johnson abbott ntm price-to-earnings
valuat calcul due rel size pharma exposur abbott alter
histor price-to-earnings trend due large-cap coverag exclud ew
end month premium smid cap coverag
end month premium acknowledg
consensu ntm price-to-earnings multipl may adequ account pro-forma ep post
larg acquisit p/e acquisit target like inflat
exhibit ms med-tech volum short interest
act financi advisor inc baxter
respect definit agreement baxter acquir seprafilm adhes
barrier relat asset sanofi announc decemb
propos transact subject certain regulatori approv customari close
condit baxter agre pay fee financi servic
includ transact fee conting upon consumm propos
transact pleas refer note end report
price earn valuat
exhibit larg cap price-to-earnings rel
exhibit organ growth segment
exhibit year stack organ growth segment
exhibit organ growth capit
exhibit year stack organ growth capit
exhibit ms med-tech coverag base case return rel current stock price
valuat methodolog risk associ price target referenc
research report pleas contact client support follow us/canada
altern may contact invest repres morgan
stanley research broadway attent research manag new york ny
exhibit ms med-tech coverag bull base bear return rel current stock price
return rel current stock price
